FDA's Marks Sees 'Two Or Three Year Window' To Transform Gene Therapy Environment

 
• By Brenda Sandburg
  
Gene therapy
FDA is focusing on ways to accelerate development of gene therapies • Source: Shutterstock

More from US FDA

More from Agency Leadership